| Bioactivity | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine |
| CAS | 2072145-79-8 |
| Formula | C32H28N2O10 |
| Molar Mass | 600.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine
CAS: 2072145-79-8 F: C32H28N2O10 W: 600.57
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs hav
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.